Plantar warts are common, stubborn, and widely misunderstood. People spend months treating them with the wrong products, confuse them with calluses, or wait for them to disappear on their own while they quietly spread. This guide covers what they actually are, what distinguishes them from lookalikes, and what the evidence says about treatment and prevention.
What Plantar Warts Are and How HPV Causes Them
A plantar wart is a benign skin growth on the sole of the foot caused by infection with human papillomavirus — specifically HPV strains 1, 2, 4, and occasionally 63. The word “plantar” refers to the sole of the foot (from the Latin planta pedis) — it has nothing to do with plants. The medical term is verruca plantaris.
Unlike warts elsewhere on the body, plantar warts are driven inward by the weight of walking rather than growing outward. The result is a growth that looks relatively flat on the surface but extends several millimeters into the dermal layers, which is why it causes pain under load and why it is more difficult to treat than warts on the hands or face.
*Approximate estimates from published dermatological literature.
How HPV infects the foot
HPV is shed from wart surfaces and survives on damp surfaces for extended periods — studies have detected viable HPV DNA on pool floors and in locker room environments hours after contamination. The virus infects through microscopic breaks in the skin: small cuts, abrasions, dry cracked heels, or the softened and macerated skin that results from prolonged moisture exposure. Intact, healthy skin is a reliable barrier; the infection requires an entry point.
This is why communal wet environments — pool decks, gym showers, locker room floors, spa facilities — carry the highest transmission risk. The combination of a contaminated surface, bare skin contact, and moisture-softened skin that increases permeability creates optimal conditions for viral entry. It’s also why protective footwear in these settings is such an effective preventive measure.
Why some people get them repeatedly and others never do
Exposure to HPV strains 1, 2, and 4 is extremely widespread — most adults have been exposed. Individual susceptibility varies based on immune response: people whose immune systems mount a vigorous T-cell response to HPV antigens clear the infection before a visible wart develops. People with reduced cellular immunity — due to age, immunosuppressive medications, HIV, or other conditions — are substantially more susceptible to wart formation and more likely to have multiple or recalcitrant warts. Children and adolescents have higher rates than older adults partly because acquired immunity develops with repeated exposure over time.
The key biology behind treatment difficulty
Unlike bacterial infections, there is no antibiotic that targets HPV directly. Every treatment works by either destroying the infected tissue (cryotherapy, salicylic acid, laser) or stimulating the immune system to recognize and clear the virus (immunotherapy). The virus itself remains in the skin until the immune system eliminates it — which is why warts can recur from the same site even after the visible lesion has been removed.
How to Tell a Plantar Wart From a Callus — the Definitive Tests
This is the most common diagnostic confusion in plantar wart management. Treating a callus with salicylic acid wart remover for weeks or treating a wart with moisturizer are both common outcomes of misidentification. Here is how to tell them apart reliably.
Plantar Wart
Viral skin growth driven inward by weight
Callus / Corn
Thickened skin from repeated friction or pressure
The pinch test — the single most reliable self-test
Pinch the lesion between your thumb and index finger, applying pressure from the sides rather than directly. A plantar wart is characteristically painful when compressed laterally — this is because the dermal nerve supply around the wart is compressed by the pinching motion. A callus is more tender when pressed directly from above. This lateral-versus-direct pain pattern reliably distinguishes the two in the vast majority of cases.
The black dot test
Using a clean nail file or pumice stone, gently pare away the surface layer of the lesion after soaking in warm water. In a plantar wart, pinpoint black or dark red dots appear — these are thrombosed (clotted) capillaries that grow into the wart tissue as part of its blood supply. This is pathognomonic for warts and does not occur in calluses, corns, or other common look-alikes. Some lesions bleed slightly when the black dots are reached — this is normal and confirms the wart diagnosis.
What if neither test is conclusive?
Mosaic warts — clusters of multiple small plantar warts merging over an area — and very early lesions may be less definitive on these tests. Any lesion that is growing rapidly, has unusual coloration (very dark, irregular pigmentation), or is not responding to 6–8 weeks of appropriate treatment should be evaluated by a dermatologist to confirm the diagnosis and rule out other conditions, including amelanotic melanoma, which can occasionally mimic plantar wart appearance.
Every Treatment Option — With Honest Effectiveness Data
Treatment selection depends on wart size, duration, patient age, immune status, and tolerance for discomfort. The options below are organized from least to most invasive. Effectiveness data reflects published randomized controlled trial results where available — not manufacturer claims.
The immune system clears approximately 65% of plantar warts in immunocompetent individuals within 2 years without intervention. For warts that are not painful, not spreading, not growing, and present in a healthy adult, watchful waiting is a clinically reasonable choice.
The relevant trade-offs: the wart may spread to adjacent skin or to other family members during this period. It may deepen and enlarge, making future treatment more difficult. And there is no way to predict which warts will resolve quickly versus persist for years. For children, the natural clearance rate is higher (approximately 78% within 2 years) — watchful waiting is more often appropriate as first management.
When NOT to wait: painful warts limiting normal activity; warts in people with diabetes or neuropathy; warts spreading rapidly or forming mosaic clusters; any wart that has been present for more than 2 years.
Salicylic acid is a keratolytic agent — it works by softening and breaking down the thickened skin of the wart, allowing the body to shed the infected tissue layer by layer. It does not directly kill the HPV virus; it destroys the infected tissue environment and allows the immune system to access and clear the virus from deeper layers.
Correct protocol for maximum effectiveness:
1. Soak the foot in warm water for 5 minutes to soften the wart surface. 2. Gently pare the white, dead surface layer with a single-use nail file or pumice stone — this improves penetration of the salicylic acid in the next application. 3. Apply the salicylic acid product (40% concentration for plantar warts is the therapeutic standard — most OTC products are adequate) precisely to the wart and cover with an occlusive dressing to maintain contact. 4. Repeat daily without exception. 5. Do not use the same nail file or pumice stone on other skin areas — they become contaminated with HPV during wart paring.
Consistency matters more than anything else with salicylic acid. Skipping days, not occluding the application, or paring too aggressively are the primary reasons it fails. Most failures are technique failures, not treatment failures.
Contraindications: Do not use on facial or genital warts, on areas with impaired circulation, or in people with diabetes or neuropathy — the keratolytic action can damage surrounding healthy tissue in these populations.
Cryotherapy uses liquid nitrogen (at approximately −196°C) to freeze the wart tissue, causing cell death and triggering an inflammatory immune response that helps the body recognize and attack the HPV-infected cells. The freeze produces a blister that lifts the wart tissue from the underlying skin; the blister roof and necrotic wart separate over 1–2 weeks as new skin forms beneath.
Each session requires 2–3 freeze-thaw cycles to achieve adequate tissue destruction. Sessions are typically repeated every 2–4 weeks until clearance — most plantar warts require 2–4 sessions. The procedure is painful during and for 24–48 hours afterward, particularly for plantar warts where surrounding tissue is dense and the wart extends deeper than on hands.
Combination cryotherapy + salicylic acid produces better outcomes than either alone. A systematic review found combination treatment increased clearance rates by approximately 15–20% compared to monotherapy. After each cryotherapy session, daily salicylic acid application during the interval between sessions maintains treatment momentum.
OTC freeze products (Compound W Freeze Off, similar) use dimethyl ether and propane at −57°C rather than liquid nitrogen. These are substantially less cold than clinical cryotherapy and have correspondingly lower clearance rates — approximately 30–40% for plantar warts. They are more appropriate for hand warts than for the thicker, deeper tissue of plantar warts.
Immunotherapy works on a different principle from destructive treatments — instead of trying to physically remove the infected tissue, it trains the immune system to recognize HPV-infected cells and attack them. The most evidence-supported approach is Candida antigen injection: a small amount of Candida skin test antigen is injected into the wart. In most people, a robust Candida immune response is already established from natural exposure. Injecting this antigen into the wart creates a local immune reaction at the site that “recruits” T cells to the area, exposing them to HPV antigens simultaneously and generating a broader anti-HPV response that can clear not just the injected wart but other warts on the body as well.
Clearance rates of 60–80% are reported for Candida antigen injection in studies of recalcitrant plantar warts. The systemic immune stimulation effect is particularly useful for patients with multiple warts — treating one site can produce clearance of untreated sites.
Topical immunotherapy with dinitrochlorobenzene (DNCB) or squaric acid dibutyl ester (SADBE) works on a contact sensitization principle — the patient is sensitized to the chemical, then dilute applications to the wart trigger localized immune activation. These are effective for recalcitrant cases but require compounding pharmacy preparation and physician management.
Pulsed dye laser (PDL) targets the hemoglobin in the thrombosed capillaries supplying the wart, coagulating the blood supply and causing wart cell death through ischemia. CO₂ laser ablates (vaporizes) the wart tissue directly. Both produce good clearance rates for plantar warts that have failed other treatments.
Advantages over surgical excision: less risk of permanent scarring, treatment is more precise, and healing time is shorter. The major limitation is cost — laser treatment is not typically covered by insurance for plantar warts and runs $200–$600 per session in most markets. Multiple sessions may be needed. HPV viral particles are present in the laser plume during treatment; proper evacuation and operator protective measures are required.
Laser is most appropriate as a second- or third-line option after salicylic acid and cryotherapy have been tried adequately, or for large mosaic warts where the treatment area makes repeated cryotherapy impractical.
Surgical excision (curettage and electrodesiccation, or simple excision) physically removes the wart and immediate surrounding tissue. The immediate clearance rate is high, but the recurrence rate is also substantial — HPV persists in clinically normal surrounding skin beyond the visible wart margin, and incomplete excision leaves the virus in place to regenerate a new lesion.
The additional concern for plantar warts specifically: the plantar surface bears full body weight with every step. Surgical scars on the sole can be permanently painful under load — a treatment outcome worse than the original wart. This is why surgical excision is generally reserved for warts that have failed all other treatments and are causing significant functional limitation.
The evidence-based preference for plantar warts is non-surgical treatment: salicylic acid, cryotherapy, and immunotherapy — with surgery as a last resort rather than a shortcut.
The evidence-based first-line recommendation
For most plantar warts in adults, the evidence-supported first-line approach is daily salicylic acid (40% concentration, properly occluded) for a full 8–12 weeks. If incomplete resolution at 8 weeks, add cryotherapy sessions every 2–3 weeks while continuing daily salicylic acid between sessions. This combination approach has the highest clearance rates among non-invasive options. Watchful waiting is appropriate for non-painful warts in healthy adults who prefer not to treat. Immunotherapy is the preferred escalation for recalcitrant cases. Surgical excision is rarely indicated.
How Footwear Affects Transmission, Pain, and Recovery
Footwear intersects with plantar warts at three distinct points: preventing initial infection through protective coverage in high-risk environments, managing the pain that makes walking with an active wart difficult, and avoiding the mechanical conditions that spread the wart to new sites. Each of these is a direct and actionable role for the right footwear choice.
Protective footwear in communal wet environments — primary prevention
HPV strains 1, 2, and 4 survive on damp surfaces for hours after contamination. Pool decks, gym showers, locker room floors, spa walkways, and communal changing facilities are all documented high-transmission environments. The virus enters through any break in the skin — a small cut, a dry crack, or macerated skin softened by prolonged moisture exposure. Going barefoot in these environments is the primary transmission pathway for plantar warts.
The standard: Flip-flops, waterproof pool sandals, or purpose-made shower shoes worn consistently in all communal wet environments. Keep a pair in the gym bag or pool bag so the decision is already made. This single habit prevents the majority of plantar wart acquisitions in high-risk settings.
Cushioning insoles during active treatment — pain management
The inward pressure of body weight on a plantar wart during walking can be intense — particularly for warts located under the heel or ball of the foot. Each step compresses the wart tissue against the hard surface beneath, irritating the surrounding nerve supply and making normal gait painful. Pain during treatment doesn’t mean the treatment is working or not working; it’s simply the mechanical reality of a lesion under load. Reducing that load reduces pain and improves treatment compliance.
The practical approach: A donut-shaped foam or gel pad placed around the wart (not over it) redistributes the pressure away from the wart site to the surrounding normal tissue. These are available at pharmacies as “moleskin with a hole” or can be cut to size from foam padding. Cushioned insoles with a pressure-relief zone at the wart location reduce pain further. Shoes with thick, shock-absorbing soles reduce total impact force at the wart site during each step.
Avoiding pressure-driven spread to new sites
Body weight on an active plantar wart creates mechanical pressure that can push viral particles into adjacent skin during the paring and treatment process. Wearing ill-fitting shoes that cause excessive friction at the wart site may also physically spread the virus from the wart surface to nearby skin with each step. This is one mechanism by which single warts spread into the mosaic pattern — a cluster of confluent smaller warts across a broad sole area that is significantly harder to treat than a single discrete lesion.
During treatment: Keep the wart covered with an occlusive dressing between treatment applications. This prevents both spread to adjacent skin and accidental contact transfer to other surfaces. Shoes with adequate toe clearance and width reduce friction at wart sites near the toes. Avoid walking barefoot at home during active wart treatment.
Breathable uppers to reduce skin maceration risk
Non-breathable shoes maintain a warm, moist environment around the foot that softens the skin continuously throughout the wear period. Macerated (over-moistened) skin is significantly more permeable to viral entry — if HPV is present in the shoe environment (from an active wart shedding) or from an external source, softened skin provides a much easier entry pathway than dry, intact skin. This is the same mechanism that makes athlete’s foot more common in non-breathable footwear.
For long-wear use: Mesh, perforated leather, or open-weave knit uppers allow continuous air exchange, preventing the sustained maceration that increases skin permeability. Changing to fresh socks mid-day reduces accumulated moisture around active warts. This is particularly important during treatment periods when wart dressings create additional localized moisture.
The footwear principle for plantar wart management
Three footwear habits cover the full scope of plantar wart risk: protective footwear in communal wet areas (prevents new infection); pressure-offloading pads and cushioned soles during treatment (manages pain and improves compliance); and breathable uppers to reduce skin maceration (reduces new-site vulnerability). None of these require specialist shoes — they are achievable with standard flip-flops for the pool, a gel pad at the pharmacy, and a breathable everyday shoe.
Five Myths About Plantar Warts — Fact-Checked
These are the five beliefs that most consistently delay appropriate treatment or create false expectations about outcome.
“Plantar warts always go away on their own — just wait it out.”
True that ~65% resolve spontaneously within 2 years in healthy adults. Not true that this applies universally or that waiting is always the right choice. Warts in people with diabetes, neuropathy, or immune compromise rarely resolve spontaneously and require treatment. Painful warts that limit walking need active treatment. And a wart that “resolves” after two years may have spread to adjacent sites during that period, converting a single, easy-to-treat lesion into a mosaic cluster requiring months of more intensive treatment.
“You can cut or dig out a plantar wart at home with a sharp instrument.”
This is both ineffective and actively harmful. The visible wart is the tip of a deeper HPV infection that extends into the dermis. Cutting away the surface tissue without eliminating the viral infection at depth simply removes the visible portion — the wart regrows from the HPV-infected tissue below within weeks. More significantly, cutting into the skin creates an open wound that can become bacterially infected, and any instrument used is contaminated with HPV and should not contact other skin. The correct approach for tissue removal is controlled paring in conjunction with salicylic acid, which removes only the dead surface layers and improves medication penetration.
“Duct tape occlusion therapy reliably cures plantar warts.”
Duct tape occlusion had a moment of genuine clinical attention after a small 2002 study found it outperformed cryotherapy. Subsequent larger, better-controlled trials have not replicated those results — the most rigorous studies show duct tape performs no better than placebo (a simple occlusive dressing) for plantar wart clearance. The mechanism proposed was that the adhesive would irritate the skin and trigger an immune response; the evidence doesn’t support this at clinically meaningful rates for plantar warts specifically. Applying an occlusive cover as part of salicylic acid treatment is genuinely useful, but the duct tape itself does not appear to be the active component. Use salicylic acid under the occlusion — not duct tape alone.
“Only children and unhygienic people get plantar warts.”
HPV exposure is nearly universal. The reason children have higher rates is not hygiene — it’s immunological. Adults who have had previous HPV 1/2/4 exposure have developed some degree of cellular immune memory that prevents wart formation in most exposures. Children encountering the virus for the first time have no such memory. Plantar warts are common in highly active adults — swimmers, gym-goers, athletes using communal facilities — regardless of hygiene practices. The relevant risk factor is barefoot contact with contaminated wet surfaces, not personal cleanliness.
“If treatment fails once, the wart can’t be treated.”
False in the general case — most warts that fail one treatment respond to a different modality or to the same treatment done correctly. The distinction between “treatment resistance” and “treatment error” is important: most apparent failures reflect technique errors (salicylic acid not properly occluded; paring too shallow; treatment stopped too early; only the symptomatic area treated), not genuine viral resistance. What is true is that warts that have persisted for more than 2 years or failed multiple correctly administered treatments may have some degree of immune evasion and benefit specifically from immunotherapy approaches rather than continued destructive treatment.
When to See a Doctor Instead of Treating at Home
Most plantar warts in healthy adults can be managed with over-the-counter salicylic acid without professional involvement. The following situations require clinical assessment rather than continued home treatment.
| Situation | Why it needs professional attention | Appropriate urgency |
|---|---|---|
| Diabetes, neuropathy, or peripheral arterial disease | Salicylic acid can damage surrounding tissue and impair wound healing in these populations; professional management required for any foot lesion | Before any self-treatment |
| Immunosuppression | Warts in immunocompromised patients are often extensive, treatment-resistant, and may require systemic approaches not available OTC | At first identification |
| Rapid growth or change in appearance | Rule out other diagnoses including amelanotic melanoma, squamous cell carcinoma in situ, and other conditions that can mimic wart appearance | Within 1–2 weeks |
| No response after 8 weeks of correct daily salicylic acid | Confirm diagnosis; assess for cryotherapy, combination treatment, or immunotherapy | Within 1 month |
| Mosaic pattern (large cluster of confluent warts) | Extensive mosaic warts typically require more aggressive treatment than OTC approaches can deliver; professional combination therapy produces better outcomes | Within 4–6 weeks |
| Significant pain limiting normal walking | Clinical treatment options reduce pain faster; persistent pain warrants professional assessment to rule out other causes | Within 2–4 weeks |
| Location on a child under 12 | Differential diagnosis in children differs from adults; some conditions mimic warts; confirm diagnosis before long OTC treatment courses | At identification |
Prevention Checklist for Everyday and High-Risk Situations
The single most effective preventive measure is protective footwear in shared wet environments. Beyond that, these habits reduce both initial infection risk and the risk of spreading an existing wart to new sites.
In communal wet environments
Always wear flip-flops or pool sandals on communal floors — without exception. Pool decks, gym showers, locker rooms, changing rooms, and spa facilities are all documented HPV transmission environments. Keep protective footwear in your gym bag so it’s already with you when needed.
Dry feet thoroughly before putting on socks and shoes after swimming or showering. Wet, softened skin is more permeable to viral entry. The transition from wet floor to enclosed shoe is a risk moment — dry first, then dress.
Do not share towels with others. Towels that have contacted a wart carry viable HPV. Personal foot towels, used once and washed before next use, eliminate this route.
Daily skin and foot maintenance
Keep dry cracked skin on heels and soles moisturized. Dry, fissured skin is a high-permeability entry point for HPV. Regular urea or glycerin-based moisturizing keeps the skin barrier intact. This is particularly important for anyone who uses communal wet facilities regularly.
Address any cuts, abrasions, or broken skin before entering communal facilities. Cover with a waterproof dressing before entering pools or gym showers. Any break in skin integrity is a potential HPV entry point.
Inspect the soles of your feet regularly. Early plantar warts are much easier to treat than established ones. A monthly look at the plantar surface — particularly heel edges, arch, and ball of foot — catches new lesions when they are small, shallow, and highly responsive to salicylic acid treatment.
If you currently have an active wart
Keep the wart covered with an occlusive dressing at all times. Between treatment applications, a waterproof dressing prevents viral shedding onto surfaces and reduces risk of spreading to adjacent skin sites.
Do not walk barefoot at home during treatment. You are shedding HPV onto your own floors. Other household members and your own other-foot skin are at risk from this shedding.
Dispose of or disinfect all paring instruments after each use. Nail files, pumice stones, and emery boards contaminated with HPV-infected tissue should be treated as single-use during active wart treatment. Never use them on non-affected skin afterward.
Use a donut-shaped pressure pad to reduce pain and compression at the wart site. This also reduces the mechanical pressure that can drive viral particles into adjacent skin during walking.
Frequently Asked Questions
The most common questions about plantar warts — answered directly.
Yes, but slowly and unpredictably. Studies show approximately 65% of plantar warts in immunocompetent individuals resolve spontaneously within two years. However, the wart may spread to adjacent skin or other family members in the interim, and it may worsen in size and depth — making later treatment harder. The 35% that don’t resolve spontaneously within two years often persist for much longer without intervention.
Treatment is recommended for any wart that is painful, growing, spreading, or present in a person with diabetes, neuropathy, or immune compromise. For small, non-painful warts in otherwise healthy adults, watchful waiting for up to 6 months is a reasonable first approach — particularly if the wart has been present less than 3 months, when spontaneous resolution is more likely.
The most reliable self-test: pinch the lesion from the sides between thumb and index finger. A plantar wart is characteristically painful when compressed laterally; a callus is more tender with direct downward pressure. Second test: after soaking in warm water and gently paring the surface, look for tiny black or dark red dots — these are thrombosed capillaries unique to warts. Calluses show only pale, uniform fibrous tissue when pared. Third feature: warts interrupt the skin line pattern (the fingerprint-like ridges on the sole stop at the wart boundary), while calluses allow the skin lines to continue through them.
Yes, though transmission requires contact with shed viral material plus a skin entry point. The primary household transmission routes are shared shower or bathroom floors (HPV shed from wart-bearing skin during every contact), shared bath mats, and shared towels. Walking barefoot on the same floor surfaces as someone with an active wart is the primary risk. Household members who share genetic susceptibility to HPV strains 1/2/4 have higher risk than those without this predisposition.
Practical household measures: disinfect shower floors regularly; avoid sharing towels; the person with the wart should keep it covered and avoid barefoot walking on shared floors during treatment. These measures protect both household members and reduce the individual’s own risk of spreading to new sites.
Recurrence after treatment has two main explanations. First — and most common — is incomplete initial clearance: the visible wart was removed but HPV remained in surrounding, clinically normal skin at a low level that the immune system didn’t fully eliminate. The virus re-establishes a visible lesion from this residual infection. Second is true reinfection from an external source — reexposure through a communal environment, walking barefoot on a contaminated bathroom floor, or re-inoculation from contaminated treatment instruments.
For the first scenario, the approach is more aggressive initial treatment combined with immunotherapy to train the immune system to clear residual virus more completely. For the second, the prevention measures in the checklist above — protective footwear, covering the wart site, disinfecting tools — are the relevant interventions. If recurrence at the same exact site happens repeatedly, immunotherapy (Candida antigen injection) is specifically designed to address the immune evasion that allows this pattern.
Children have higher spontaneous resolution rates than adults — approximately 78% within two years — making watchful waiting a more defensible first approach in children than in adults. If the wart is small, not painful, not spreading, and not causing the child any distress, waiting 3–6 months before initiating treatment is reasonable.
Treat if: the wart is painful enough to affect the child’s walking, sport, or activity; it is visibly growing or spreading; the child is embarrassed by it (this has real quality-of-life impact); or it has been present for over 6 months without any change. For children, low-concentration salicylic acid (26–17%, lower than the 40% adult formulation) applied with parental assistance produces good results. Cryotherapy is effective but more painful and may require topical anesthetic in young children. A dermatologist consultation for any wart in a child under 5 is appropriate, as differential diagnoses differ from older children and adults.
For people with diabetes, plantar warts should not be self-treated with salicylic acid. This is explicitly stated in most product labeling — salicylic acid is keratolytic, meaning it destroys tissue, and in diabetic patients with impaired wound healing and neuropathy, it can cause skin ulceration at the treatment site without the person feeling it developing. The result can be a wound worse than the original wart in a foot that heals poorly.
All foot lesions in diabetic patients — including plantar warts — should be assessed by a podiatrist who can determine the appropriate treatment, manage it professionally, and monitor the response. Clinical cryotherapy, laser, or immunotherapy can be used safely in this population with appropriate monitoring. Footwear management is particularly relevant: pressure-offloading around the wart site using properly fitted shoes with cushioned soles and a donut pad reduces the mechanical load that can cause tissue breakdown around the lesion — addressing both pain and wound-prevention concerns simultaneously.
Disclaimer: This article is for general educational and informational purposes only and does not constitute medical advice. Plantar wart diagnosis and treatment should be confirmed by a licensed dermatologist or podiatrist for any lesion of uncertain diagnosis, any lesion not responding to appropriate home treatment, or any lesion in a person with diabetes, neuropathy, circulatory disease, or immunosuppression. Do not use salicylic acid on foot lesions without a confirmed diagnosis if you have diabetes.
You may also like
-
Sale!
Breathable and lightweight sports shoes – Ergonomically designed, soft and comfortable orthopedic men’s sports shoes (provide arch support and relieve discomfort)
Original price was: $119.90.$59.90Current price is: $59.90. -
DUORO Mens Slip On Road Running Shoes Breathable Lightweight Comfortable Walking Shoes Athletic Gym Tennis Shoes for Men
$39.99 -
Sale!
FEFELUIS Men’s Barefoot Wide Toe Box Shoes – Minimalist Dress | Zero Drop | Slip On for Walking NUT Size 8 Wide | Walking
Original price was: $59.99.$31.97Current price is: $31.97. -
Sale!
Grounded Footwear Barefoot Shoes
Original price was: $139.98.$69.99Current price is: $69.99.